Chongkundang Holdings Corp logo

Chongkundang Holdings Corp (001630)

Market Closed
25 Jul, 06:30
KRX SM KRX SM
52,000. 00
0
0%
247.55B Market Cap
- P/E Ratio
5,600% Div Yield
3,424 Volume
- Eps
52,000
Previous Close
Day Range
51,400 52,500
Year Range
40,700 60,700
Want to track 001630 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 18 days

Summary

001630 closed today higher at ₩52,000, an increase of 0% from yesterday's close, completing a monthly increase of or ₩52,000. Over the past 12 months, 001630 stock gained .
001630 is not paying dividends to its shareholders.
The last earnings report, released on May 16, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 415.81%, based on the last three reports. The next scheduled earnings report is due on Aug 12, 2025.
Chongkundang Holdings Corp has completed 1 stock splits, with the recent split occurring on Dec 06, 2013.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on KRX SM (KRW).

001630 Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.

Chongkundang Holdings Corp Dividends

Chongkundang Holdings Corp logo
001630 6 months ago
Other
₩1,400 Per Share
Chongkundang Holdings Corp logo
001630 27 Dec 2023
Other
₩1,400 Per Share
Chongkundang Holdings Corp logo
001630 28 Dec 2022
Other
₩1,400 Per Share
Chongkundang Holdings Corp logo
001630 29 Dec 2021
Other
₩1,400 Per Share
Chongkundang Holdings Corp logo
001630 29 Dec 2020
Other
₩1,400 Per Share

Chongkundang Holdings Corp Earnings

12 Aug 2025 (In 2 weeks) Date
-
Cons. EPS
-
EPS
16 May 2025 Date
-
Cons. EPS
-
EPS
15 May 2025 Date
-
Cons. EPS
1.25K
EPS
14 May 2025 Date
-
Cons. EPS
-
EPS
11 Feb 2025 Date
-
Cons. EPS
-
EPS
Chongkundang Holdings Corp logo
001630 6 months ago
Other
₩1,400 Per Share
Chongkundang Holdings Corp logo
001630 27 Dec 2023
Other
₩1,400 Per Share
Chongkundang Holdings Corp logo
001630 28 Dec 2022
Other
₩1,400 Per Share
Chongkundang Holdings Corp logo
001630 29 Dec 2021
Other
₩1,400 Per Share
Chongkundang Holdings Corp logo
001630 29 Dec 2020
Other
₩1,400 Per Share
12 Aug 2025 (In 2 weeks) Date
-
Cons. EPS
-
EPS
16 May 2025 Date
-
Cons. EPS
-
EPS
15 May 2025 Date
-
Cons. EPS
1.25K
EPS
14 May 2025 Date
-
Cons. EPS
-
EPS
11 Feb 2025 Date
-
Cons. EPS
-
EPS

Chongkundang Holdings Corp (001630) FAQ

What is the stock price today?

The current price is ₩52,000.00.

On which exchange is it traded?

Chongkundang Holdings Corp is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 001630.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 5,600%.

What is its market cap?

As of today, the market cap is 247.55B.

When is the next earnings date?

The next earnings report will release on Aug 12, 2025.

Has Chongkundang Holdings Corp ever had a stock split?

Chongkundang Holdings Corp had 1 splits and the recent split was on Dec 06, 2013.

Chongkundang Holdings Corp Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Tae Young Kim CEO
KRX SM Exchange
KR7001630003 ISIN
KR Country
37 Employees
- Last Dividend
6 Dec 2013 Last Split
- IPO Date

Overview

Chong Kun Dang Holdings Corp. is a well-established entity in the pharmaceutical industry, focusing on the manufacture and distribution of pharmaceutical products. With its inception in 1941, it has grown to serve not only the domestic market in South Korea but also an international clientele. The headquarters of Chong Kun Dang Holdings Corp. is located in Seoul, South Korea, indicating its central role in the country’s pharmaceutical landscape. Through decades of operation, the company has built a reputation for delivering quality pharmaceutical products, contributing to healthcare and medical treatments worldwide.

Products and Services

Chong Kun Dang Holdings Corp. offers a diverse portfolio of pharmaceutical products that cater to a wide range of medical needs. The company's products and services include:

  • Prescription Medicines: These include drugs for various diseases and conditions, requiring a doctor's prescription for purchase. Chong Kun Dang Holdings Corp. invests in research and development to bring innovative drugs to the market, aiding in the treatment of complex health conditions.
  • Over-the-Counter (OTC) Drugs: Catering to common health issues, these drugs are available without a prescription, offering convenience and immediate relief to consumers. The range includes pain relievers, cold and allergy medications, and digestive aids, among others.
  • Biopharmaceuticals: Leveraging biotechnology, the company develops biopharmaceutical products that include vaccines and biosimilar drugs. These products play a crucial role in preventive healthcare and the treatment of chronic conditions, offering new hope for patients.
  • Health Supplements: Understanding the growing focus on preventive healthcare, Chong Kun Dang Holdings Corp. offers a range of health supplements. These products aim to support overall health and well-being, complementing diets and lifestyle choices.

Contact Information

Address: 8, Chungjeong-ro, Seoul, South Korea
Phone: 82 2 6373 0600